Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Molecular Neurobiology|August 10, 2017
Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In VivoFrancesca Vaglini, Carla Pardini, Teresa Di Desidero, et al.
Current Cancer Drug Targets|January 22, 2010
Targeting vascular endothelial growth factor pathway in first-line treatment of metastatic colorectal cancer: state-of-the-art and future perspectives in clinical and molecular selection of patientsFotios Loupakis, Guido Bocci, Giuseppe Pasqualetti, et al.
Molecular Cancer Research : MCR|July 6, 2004
A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasmaJohn M L Ebos, Guido Bocci, Shan Man, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical CenterLetizia Biso, Marco Carli, Shivakumar Kolachalam, et al.
Molecular Cancer Therapeutics|October 18, 2005
Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agentsGiulio Francia, Shane K Green, Guido Bocci, et al.
Cancer Letters|October 2, 2017
Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancerTeresa Di Desidero, Alessandro Antonelli, Paola Orlandi, et al.
Current Cancer Drug Targets|November 25, 2005
Cellular and molecular surrogate markers to monitor targeted and non-targeted antiangiogenic drug activity and determine optimal biologic doseYuval Shaked, Guido Bocci, Raquel Munoz, et al.
Cancers|January 28, 2026
Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective AnalysisSabrina Pelliccia, Marta Banchi, Lucrezia De Marchi, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicityGuido Bocci, Cecilia Barbara, Francesca Vannozzi, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1Guido Bocci, Anna Fioravanti, Paola Orlandi, et al.
Pageof 16